34
Participants
Start Date
May 24, 2021
Primary Completion Date
May 8, 2024
Study Completion Date
May 8, 2024
Bocidelpar
Oral
Placebo
Oral
Columbia University Irving Medical Center, New York
Children's Hospital of Philadelphia, Philadelphia
Cleveland Clinic, Cleveland
Akron Children's Hospital, Akron
Baylor College of Medicine, Houston
University of Texas Health Science Center at Hosuton, Houston
Children's Hospital Colorado, Aurora
University of California, San Diego, La Jolla
Stanford University Medical Center, Stanford
Seattle Children's Hospital, Seattle
Massachusetts General Hospital, Boston
Lead Sponsor
Astellas Pharma Inc
INDUSTRY